House Judiciary Committee Subpoenas Former Pfizer Executive Amid Covid-19 Vaccine Investigation

Strategic Insights -

The House Judiciary Committee has issued a subpoena to Dr. Philip Dormitzer, a former Pfizer executive, in connection with its investigation into allegations of a delayed clinical testing process for Pfizer's Covid-19 vaccine. This move comes after the committee received information from British drugmaker GSK that Dormitzer had told his colleagues that Pfizer had intentionally delayed announcing the vaccine's effectiveness until after the 2020 presidential election. Dormitzer has disputed these claims, stating that Pfizer aimed to secure FDA approval at the earliest possible moment. The committee has alleged that Pfizer's announcement about the vaccine's effectiveness came nearly a week after Election Day, fueling speculation about the company's motivations.

Key Takeaways:

  • The House Judiciary Committee has issued a subpoena to Dr. Philip Dormitzer, a former Pfizer executive, in connection with its investigation into the Covid-19 vaccine's development timeline.
  • The committee has received information from GSK that Dormitzer told his colleagues that Pfizer intentionally delayed announcing the vaccine's effectiveness until after the 2020 presidential election.
  • Dormitzer has disputed these claims, stating that Pfizer aimed to secure FDA approval at the earliest possible moment.
  • The committee has alleged that Pfizer's announcement about the vaccine's effectiveness came nearly a week after Election Day, sparking speculation about the company's motivations.
  • Pfizer CEO Albert Bourla has denied any political motivation behind the announcement, stating that the timing had nothing to do with the election.
  • GSK has provided the committee with information about Dormitzer's interactions with a human resources representative, including a comment about the "timing of the vaccine" being "not a coincidence."
  • The committee has also sought information from Pfizer directly, but has not issued the company a subpoena.

Statistics:

  • The Covid-19 vaccine was announced effective nearly a week after the 2020 presidential election.
  • Dr. Philip Dormitzer leaves Pfizer to work for GSK in 2021.
  • GSK's human resources representative recalls a meeting with Dormitzer where he expressed concerns about being investigated by the Trump Administration.
  • The House Judiciary Committee received information from GSK about Dormitzer's November 2024 interactions with the human resources representative.

Sources:

  • CNN, "House Judiciary Committee subpoenas former Pfizer executive in COVID-19 vaccine investigation"
  • The Wall Street Journal, "Pfizer's Covid Vaccine Development Timeline Questioned by the Company's Former Executive"
  • Letter from House Judiciary Chair Jim Jordan to Dr. Philip Dormitzer, obtained by CNN